Gene, Subunit | Total | RVISa | AD | ASD | DD/MR | Epi | SZ | ADD |
---|---|---|---|---|---|---|---|---|
% | ||||||||
GABRA1, α1 | 13 | 24 | 0 | 0 | 0 | 12 | 1 | 0 |
GABRA2, α2 | 11 | 34 | 0 | 1 | 1 | 0 | 0 | 9 |
GABRA6, α6 | 3 | 68 | 0 | 0 | 0 | 0 | 2 | 1 |
GABRB2, β2 | 7 | 15 | 0 | 2 | 0 | 0 | 5 | 0 |
GABRB3, β3 | 7 | 22 | 0 | 1 | 0 | 5 | 0 | 1 |
GABRG1, γ1 | 4 | 12 | 0 | 0 | 0 | 0 | 0 | 4 |
GABRG2, γ2 | 9 | 25 | 0 | 0 | 0 | 8 | 1 | 0 |
GABRG3, γ3 | 2 | 46 | 1 | 1 | 0 | 0 | 0 | 0 |
GABRR2, ρ2 | 6 | 59 | 0 | 1 | 0 | 0 | 0 | 5 |
GABRD, δ | 2 | 59 | 0 | 0 | 0 | 2 | 0 | 0 |
Total | 64 | 1 | 6 | 1 | 27 | 9 | 20 |
AD, Alzheimer’s disease; ADD, addiction; ASD, autism spectrum disorder; DD, developmental delay; Epi, epilepsy; MR, mental retardation; SZ, schizophrenia.
↵a RVIS is the residual variation intolerance score in percentile, for which lower numbers reflect genes less tolerant to mutation (see dataset S2 in Petrovski et al., 2013; http://www.plosgenetics.org/article/fetchSingleRepresentation.action?uri=info:doi/10.1371/journal.pgen.1003709.s002; see Supplemental Table S1 for references).